Cellectis SA
(XPAR:ALCLS)
€
1.53
+0.0080 (+0.53%)
Market Cap: 153.50 Mil
Enterprise Value: 25.29 Mil
PE Ratio: 0
PB Ratio: 1.03
GF Score: 46/100 Cellectis SA at Barclays Virtual Gene Editing & Gene Therapy Summit - Presentation Transcript
Nov 16, 2020 / 02:15PM GMT
Release Date Price:
€16.64
(+4.39%)
Huidong Wang
Barclays Bank PLC, Research Division - Research Analyst
Thank you, everyone. Welcome to our next speakers from Cellectis. Today with me, we have André Choulika, the Chief Executive Officer; Carrie Brownstein, Chief Medical Officer; and also Simon Harnest, SVP of Corporate Strategy and Finance.
With that, I hand over to André.
AndrÃ;Choulika
Cellectis S.A. - Co-Founder, CEO & Director
© -
Well, thank you very much, Gena. I think that
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |

30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot
